Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / monday investor deadline robbins geller rudman dowd mwn benzinga


MDRX - MONDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Veradigm Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MDRX | Benzinga

  • SAN DIEGO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers of Veradigm Inc. (NASDAQ:MDRX) common stock between February 26, 2021 and December 7, 2023, all dates inclusive (the "Class Period"), have until Monday, January 22, 2024 to seek appointment as lead plaintiff of the Veradigm class action lawsuit. Captioned Erwin v. Veradigm Inc., No. 23-cv-16205 (N.D. Ill.), the Veradigm class action lawsuit charges Veradigm and certain of its current and former top executive officers with violations of the Securities Exchange Act of 1934.

    If you suffered substantial losses and wish to serve as lead plaintiff of the Veradigm class action lawsuit, please provide your information here:

    https://www.rgrdlaw.com/cases-veradigm-inc-class-action-lawsuit-mdrx.html

    You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800/449-4900 or via e-mail at jsanchez@rgrdlaw.com.

    CASE ALLEGATIONS: The Veradigm class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) Veradigm had overstated its historical revenues by at least $20 million; (ii) Veradigm had artificially inflated its revenue by recording duplicate transactions, among other things, over a more than two-year period; (iii) Veradigm had artificially inflated its earnings and margins and materially misrepresented demand for Veradigm's products and services; (iv) Veradigm had failed to maintain effective internal controls over its financial reporting; and (v) Veradigm had failed to comply with Generally Accepted Accounting Principles regarding appropriate revenue recognition practices.

    On February 28, ...

    Full story available on Benzinga.com

  • Stock Information

    Company Name: Allscripts Healthcare Solutions Inc.
    Stock Symbol: MDRX
    Market: NASDAQ

    Menu

    MDRX MDRX Quote MDRX Short MDRX News MDRX Articles MDRX Message Board
    Get MDRX Alerts

    News, Short Squeeze, Breakout and More Instantly...